EP Patent

EP3501506A1 — Pharmaceutical tablet composition comprising brexpiprazole

Assigned to Alfred E Tiefenbacher GmbH and Co KG · Expires 2019-06-26 · 7y expired

What this patent protects

The invention relates to a pharmaceutical composition in the form of a tablet, comprising a) brexpiprazole as active ingredient and b) at least 5% by weight (wt%) pregelatinized starch (PGS). The invention further relates to methods of preparing a pharmaceutical composition in th…

USPTO Abstract

The invention relates to a pharmaceutical composition in the form of a tablet, comprising a) brexpiprazole as active ingredient and b) at least 5% by weight (wt%) pregelatinized starch (PGS). The invention further relates to methods of preparing a pharmaceutical composition in the form of a tablet, comprising dry granulation of a blend of the components to produce granules and compression of the granules to a tablet. The invention further relates to the use of the composition in the treatment of schizophrenia, major depression, and other central nervous system disorders.

Drugs covered by this patent

Patent Metadata

Patent number
EP3501506A1
Jurisdiction
EP
Classification
—
Expires
2019-06-26
Drug substance claim
No
Drug product claim
No
Assignee
Alfred E Tiefenbacher GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.